FIELD: organic chemistry, medicine, chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition comprising 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylic acid or 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylate used for prophylaxis, treatment or inhibition of development of simple retinopathy or preproliferative retinopathy. Also, invention relates to a method for prophylaxis, treatment of inhibition of development of simple retinopathy or preproliferative retinopathy and to applying 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylic acid or 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylate. Pharmaceutical composition elicits the enhanced effectiveness and bioavailability.
EFFECT: valuable medicinal properties of composition.
4 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION CONTAINING A COMPOUND OF ANGIOTENSIN II-ANTAGONISTIC ACTIVITY | 1997 |
|
RU2188013C2 |
| HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD OF ANTAGONISM OF ANGIOTENSIN-II | 1992 |
|
RU2168510C2 |
| PYRIMIDINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1994 |
|
RU2098411C1 |
| BENZIMIDAZOLE DERIVATIVES, TAUTOMERS OR SALTS THEREOF AND DRUG HAVING ANTAGONISTIC ANGIOTENSINE II EFFECT | 1993 |
|
RU2126401C1 |
| USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY | 2006 |
|
RU2497513C2 |
| TETRAZOLE DERIVATIVE-CONTAINING OPHTHALMIC SOLUTIONS | 2003 |
|
RU2318493C2 |
| PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2198682C2 |
| PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2323004C2 |
| AGENT WHICH PREVENTS PREMATURE OVULATION | 2006 |
|
RU2419435C2 |
| SULFATED AMINO ACID DERIVATIVES AND METALLOPROTEINASE INHIBITORS COMPRISING THEREOF | 1997 |
|
RU2198656C2 |
